Mark Spence

Showing 1-11 of 11 articles

Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy

Ladwiniec A, Walsh S, Holm N, Hanratty C, Mäkikallio T, Kellerth T, Hildick-Smith D, Mogensen L, Hartikainen J, Menown I, Erglis A, Eriksen E, Spence M, Thuesen L, Christiansen E

June 25, 2020 | 10.4244/EIJ-D-19-01003

Incidence of “Shocktopics” and asynchronous cardiac pacing in patients undergoing coronary intravascular lithotripsy

Wilson S, Spratt J, Hill J, Spence M, Cosgrove C, Jones J, Strange J, Halperin H, Walsh S, Hanratty C

March 20, 2020 | 10.4244/EIJ-D-19-00484

Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial

Barbanti M, van Mourik M, Spence M, Iacovelli F, Martinelli G, Muir D, Saia F, Bortone A, Densem C, van der Kley F, Bramlage P, Vis M, Tamburino C

June 20, 2019 | 10.4244/EIJ-D-18-01197

Considering the optimal procedural Heart Team in TAVI: back to the future?

Brennan P, Jeganathan R, Spence M

April 5, 2019 | 10.4244/EIJV14I18A315

Interventions for valvular disease

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

Interventions for valvular disease

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01025

Peripheral interventions

How should I treat an asymptomatic aortic coarctation with a concomitant dissection of the descending aorta?

Gheorghe L, Arzamendi D, Li C, Barros-Membrilla A, Munoz J, Penaranda A, Sultan S, Spence M, Collins A

March 20, 2017 | 10.4244/EIJ-D-16-00169

Coronary interventions

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Fajadet J, Neumann F, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S

January 20, 2017 | 10.4244/EIJV12I13A262

Interventions for valvular disease

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial

Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence M, Redwood S, Kahlert P, Rodés-Cabau J, Leipsic J, Webb J

June 10, 2016 | 10.4244/EIJV12I2A37

St Jude Medical Portico valve

Manoharan G, Spence M, Rodés-Cabau J, Webb J

September 30, 2012 | 10.4244/EIJV8SQA18

How should I treat a patient to remove a fractured jailed side branch wire?

Owens C, Spence M

August 30, 2011 | 10.4244/EIJV7I4A83

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers